Stock HIMS HIMS & HERS HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Hims & Hers Health, Inc.

Equities

HIMS

US4330001060

Market Closed - Nyse
Other stock markets
 01:30:02 27/04/2024 am IST 		5-day change 1st Jan Change
12.5 USD +1.87% Intraday chart for Hims & Hers Health, Inc. +5.04% +40.45%
26/04 Seaport Global Starts Hims & Hers Health With Buy Rating MT
16/04 Jefferies Downgrades Hims & Hers Health to Hold From Buy, Cuts Price Target to $15 From $17 MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • The company is in a robust financial situation considering its net cash and margin position.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • The company does not generate enough profits, which is an alarming weak point.
  • With an expected P/E ratio at 153.58 and 52.81 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
HIMS & HERS HEALTH, INC. Stock Hims & Hers Health, Inc.
+40.45% 2.68B -
TELADOC HEALTH, INC. Stock Teladoc Health, Inc.
-39.63% 2.21B
D+
TALKSPACE, INC. Stock Talkspace, Inc.
+22.83% 527M -
QDM INTERNATIONAL INC. Stock QDM International Inc.
+42.77% 467M - -
AMERICAN WELL CORPORATION Stock American Well Corporation
-64.56% 157M
C-
SHL TELEMEDICINE LTD. Stock SHL Telemedicine Ltd.
-31.65% 85.12M -
C-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. HIMS Stock
  4. Ratings Hims & Hers Health, Inc.